Page last updated: 2024-12-07
s 2366
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
S 2366: chromogenic substrate for Factor XI in plasma [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 126364 |
SCHEMBL ID | 1418691 |
MeSH ID | M0119798 |
Synonyms (18)
Synonym |
---|
s 2366 |
(2s)-n-[(2s)-5-(diaminomethylideneamino)-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-[(2s)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide |
72194-57-1 |
pglu-pro-arg-pna |
pyroglutamyl-prolyl-arginine-4-nitroanilide |
s-2366 , |
l-agrininamide, 5-oxo-l-prolyl-l-prolyl-n-(4-nitrophenyl)- |
(2s)-5-carbamimidamido-n-(4-nitrophenyl)-2-{[(2s)-1-{[(2s)-5-oxopyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamide hydrochloride |
glu-pro-arg-pna |
hepsin chromogenic substrate |
bdbm13573 |
l-pyroglutamyl-l-prolyl-l-argininep-nitroaniline |
chromogenic substrate s-2366 |
l-pyroglutamyl-l-prolyl-l-arginine-p-nitroaniline |
SCHEMBL1418691 |
DTXSID70992908 |
n-[5-carbamimidamido-1-(4-nitroanilino)-1-oxopentan-2-yl]-1-(5-hydroxy-3,4-dihydro-2h-pyrrole-2-carbonyl)pyrrolidine-2-carboximidic acid |
pyr-ro-rg-na |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (17)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.58
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.58) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |